A global diagnostics company aims to introduce its rapid PCRun diagnostic test for leptospirosis into the competitive and regulated Chinese in vitro diagnostics (IVD) market.

Conducted a thorough market assessment and created a heat map of distributor networks and sales structures, facilitating the client in developing a targeted GTM strategy, portfolio planning, and understanding workforce requirements for specific APAC markets, including China.

Utilized sentiment analysis and opinion mining to evaluate public sentiment regarding the client's products and topics, to understand patient preferences, manage brand perception, identify competitive advantages, and gather feedback for product improvement. Our insights enabled data-driven decision-making and strengthened their market strategy.

Monitored and analyzed KOLs' content, reach, and engagement metrics, engaging them to collaborate on educational initiatives and amplify messaging. Regularly updating, tracking lists, and monitoring KOL impact through digital listening helped to stay informed about emerging voices in the healthcare industry.

Carried out a literature review and gap analysis using PubMed data to analyze specific MOAs and indications. Monthly newsletters and dashboards with insights, helped the client understand research trends, identify opportunities, and pinpoint gaps in their focus areas.

Summarized quarterly investor calls through transcripts and presentations of global biopharma companies, focusing on their oncology assets and partnerships for molecules. Provided strategic insights, aiding the client in staying competitive and pursuing partnerships effectively.